v3.25.4
Restructuring Costs
 9 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Impairment Costs Disclosure RESTRUCTURING AND IMPAIRMENT COSTS
Universal regularly reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities.
Tobacco Operations
During the nine months ended December 31, 2024, the Company began consolidating its European sheet tobacco operations into the Company's facility in the Netherlands, by initiating a wind-down of activities at its sheet facility in Germany, incurring $10.5 million of restructuring and impairment costs. During the nine months ended December 31, 2025, the Company recognized an additional $0.7 million of restructuring costs and $1.0 million of impairment costs related to the consolidation of the sheet tobacco operations. The Company also incurred $0.1 million of termination and impairment costs in other areas of the Tobacco Operations segment in both the nine months ended December 31, 2025 and 2024.
A summary of the restructuring and impairment costs recorded for the three and nine months ended December 31, 2025 and 2024 was as follows:
Three Months Ended December 31,Nine Months Ended December 31,
(in thousands)2025202420252024
Restructuring costs:
  Employee termination benefits$— $— $122 $4,342 
  Other711 — 711 1,372 
    Total restructuring costs711 — 833 5,714 
Impairment costs:
  Property, plant and equipment— — 1,000 4,859 
    Total impairment costs— — 1,000 4,859 
      Total restructuring and impairment costs$711 $— $1,833 $10,573